CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR ‐506‐3p/ NFIB axis
Author:
Affiliation:
1. The Fourth Clinical Medical College Zhejiang Chinese Medical University Hangzhou China
2. Department of Radiotherapy, Affiliated Hangzhou Cancer Hospital Zhejiang University School of Medicine Hangzhou China
Funder
Hangzhou Science and Technology Bureau
Publisher
Wiley
Subject
Drug Discovery
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21882
Reference34 articles.
1. Ovarian cancer: strategies for overcoming resistance to chemotherapy
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
4. Mechanisms of Cancer Drug Resistance
5. Knockdown of circular RNA Hsa_circ_0000714 can regulate RAB17 by sponging miR‐370‐3p to reduce paclitaxel resistance of ovarian cancer through CDK6/RB pathway;Guo M.;Oncotargets and Therapy,2020
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hsa_circRNA_007630 knockdown delays colon cancer progression by modulation of ferroptosis via miR‐506‐3p/AURKA axis;Journal of Biochemical and Molecular Toxicology;2024-07-17
2. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective;Cellular & Molecular Biology Letters;2024-04-26
3. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28
4. The role of circRNAs in regulation of drug resistance in ovarian cancer;Frontiers in Genetics;2023-12-13
5. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6;Journal of Ovarian Research;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3